CN107375075A - 一种用于防治痤疮的护肤面膜液、制备方法及护肤面膜 - Google Patents
一种用于防治痤疮的护肤面膜液、制备方法及护肤面膜 Download PDFInfo
- Publication number
- CN107375075A CN107375075A CN201710638134.XA CN201710638134A CN107375075A CN 107375075 A CN107375075 A CN 107375075A CN 201710638134 A CN201710638134 A CN 201710638134A CN 107375075 A CN107375075 A CN 107375075A
- Authority
- CN
- China
- Prior art keywords
- parts
- facial treatment
- acne
- treatment mask
- liquid
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000007788 liquid Substances 0.000 title claims abstract description 92
- 230000001815 facial effect Effects 0.000 title claims abstract description 71
- 206010000496 acne Diseases 0.000 title claims abstract description 55
- 208000002874 Acne Vulgaris Diseases 0.000 title claims abstract description 54
- 238000002360 preparation method Methods 0.000 title claims abstract description 14
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims abstract description 61
- 235000007516 Chrysanthemum Nutrition 0.000 claims abstract description 28
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 claims abstract description 28
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 claims abstract description 28
- 239000003814 drug Substances 0.000 claims abstract description 23
- 244000189548 Chrysanthemum x morifolium Species 0.000 claims abstract description 22
- 244000302544 Luffa aegyptiaca Species 0.000 claims abstract description 16
- 235000009814 Luffa aegyptiaca Nutrition 0.000 claims abstract description 16
- 239000004094 surface-active agent Substances 0.000 claims abstract description 16
- 235000011187 glycerol Nutrition 0.000 claims abstract description 14
- 239000004310 lactic acid Substances 0.000 claims abstract description 14
- 235000014655 lactic acid Nutrition 0.000 claims abstract description 14
- 235000009917 Crataegus X brevipes Nutrition 0.000 claims abstract description 13
- 235000013204 Crataegus X haemacarpa Nutrition 0.000 claims abstract description 13
- 235000009685 Crataegus X maligna Nutrition 0.000 claims abstract description 13
- 235000009444 Crataegus X rubrocarnea Nutrition 0.000 claims abstract description 13
- 235000009486 Crataegus bullatus Nutrition 0.000 claims abstract description 13
- 235000017181 Crataegus chrysocarpa Nutrition 0.000 claims abstract description 13
- 235000009682 Crataegus limnophila Nutrition 0.000 claims abstract description 13
- 240000000171 Crataegus monogyna Species 0.000 claims abstract description 13
- 235000004423 Crataegus monogyna Nutrition 0.000 claims abstract description 13
- 235000002313 Crataegus paludosa Nutrition 0.000 claims abstract description 13
- 235000009840 Crataegus x incaedua Nutrition 0.000 claims abstract description 13
- 240000007164 Salvia officinalis Species 0.000 claims abstract description 13
- 235000005412 red sage Nutrition 0.000 claims abstract description 13
- 235000000604 Chrysanthemum parthenium Nutrition 0.000 claims abstract description 12
- 235000000802 Leonurus cardiaca ssp. villosus Nutrition 0.000 claims abstract description 12
- 244000131316 Panax pseudoginseng Species 0.000 claims abstract description 12
- 235000003181 Panax pseudoginseng Nutrition 0.000 claims abstract description 12
- IDGUHHHQCWSQLU-UHFFFAOYSA-N ethanol;hydrate Chemical compound O.CCO IDGUHHHQCWSQLU-UHFFFAOYSA-N 0.000 claims abstract description 12
- 229920001661 Chitosan Polymers 0.000 claims abstract description 11
- 239000008367 deionised water Substances 0.000 claims abstract description 11
- 229910021641 deionized water Inorganic materials 0.000 claims abstract description 11
- 239000000463 material Substances 0.000 claims abstract description 11
- 240000004670 Glycyrrhiza echinata Species 0.000 claims abstract description 9
- 235000001453 Glycyrrhiza echinata Nutrition 0.000 claims abstract description 9
- 235000006200 Glycyrrhiza glabra Nutrition 0.000 claims abstract description 9
- 235000017382 Glycyrrhiza lepidota Nutrition 0.000 claims abstract description 9
- 229940010454 licorice Drugs 0.000 claims abstract description 9
- 240000007890 Leonurus cardiaca Species 0.000 claims abstract 3
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 19
- 239000000203 mixture Substances 0.000 claims description 14
- 235000007866 Chamaemelum nobile Nutrition 0.000 claims description 11
- 235000016622 Filipendula ulmaria Nutrition 0.000 claims description 11
- 244000042664 Matricaria chamomilla Species 0.000 claims description 11
- 235000007232 Matricaria chamomilla Nutrition 0.000 claims description 11
- 244000228451 Stevia rebaudiana Species 0.000 claims description 11
- 235000006092 Stevia rebaudiana Nutrition 0.000 claims description 11
- 239000012535 impurity Substances 0.000 claims description 10
- 238000000605 extraction Methods 0.000 claims description 9
- 238000010992 reflux Methods 0.000 claims description 9
- 230000001804 emulsifying effect Effects 0.000 claims description 7
- 238000002156 mixing Methods 0.000 claims description 7
- 240000005250 Chrysanthemum indicum Species 0.000 claims description 6
- 238000001914 filtration Methods 0.000 claims description 6
- 239000000706 filtrate Substances 0.000 claims description 5
- 238000000926 separation method Methods 0.000 claims description 5
- 239000007787 solid Substances 0.000 claims description 5
- 238000003756 stirring Methods 0.000 claims description 5
- 235000010482 polyoxyethylene sorbitan monooleate Nutrition 0.000 claims description 3
- 229920000053 polysorbate 80 Polymers 0.000 claims description 3
- 150000004676 glycans Chemical class 0.000 claims description 2
- 238000002791 soaking Methods 0.000 claims description 2
- 244000061544 Filipendula vulgaris Species 0.000 claims 2
- 230000000694 effects Effects 0.000 abstract description 25
- 230000003115 biocidal effect Effects 0.000 abstract description 5
- 230000001225 therapeutic effect Effects 0.000 abstract description 5
- 230000003110 anti-inflammatory effect Effects 0.000 abstract description 4
- 230000003902 lesion Effects 0.000 abstract description 4
- 241000186427 Cutibacterium acnes Species 0.000 abstract description 3
- 241000191967 Staphylococcus aureus Species 0.000 abstract description 3
- 241000191963 Staphylococcus epidermidis Species 0.000 abstract description 3
- 229940055019 propionibacterium acne Drugs 0.000 abstract description 3
- 230000003449 preventive effect Effects 0.000 abstract description 2
- 210000003491 skin Anatomy 0.000 description 18
- 241000207925 Leonurus Species 0.000 description 9
- 241000957095 Spiraea alba Species 0.000 description 9
- 206010040882 skin lesion Diseases 0.000 description 8
- 231100000444 skin lesion Toxicity 0.000 description 8
- 230000036407 pain Effects 0.000 description 6
- 239000000758 substrate Substances 0.000 description 6
- 238000000034 method Methods 0.000 description 5
- 230000028327 secretion Effects 0.000 description 5
- 239000000243 solution Substances 0.000 description 5
- 238000012360 testing method Methods 0.000 description 5
- 231100001274 therapeutic index Toxicity 0.000 description 5
- 210000002374 sebum Anatomy 0.000 description 4
- 241000894006 Bacteria Species 0.000 description 3
- 244000025254 Cannabis sativa Species 0.000 description 3
- 206010061218 Inflammation Diseases 0.000 description 3
- 239000004480 active ingredient Substances 0.000 description 3
- 238000001467 acupuncture Methods 0.000 description 3
- 235000009508 confectionery Nutrition 0.000 description 3
- 238000011156 evaluation Methods 0.000 description 3
- 239000004744 fabric Substances 0.000 description 3
- 238000007654 immersion Methods 0.000 description 3
- 230000004054 inflammatory process Effects 0.000 description 3
- 238000011084 recovery Methods 0.000 description 3
- 231100000241 scar Toxicity 0.000 description 3
- 206010028980 Neoplasm Diseases 0.000 description 2
- 206010033733 Papule Diseases 0.000 description 2
- AIGAZQPHXLWMOJ-UHFFFAOYSA-N Tanshinone I Chemical compound C1=CC2=C(C)C=CC=C2C(C(=O)C2=O)=C1C1=C2C(C)=CO1 AIGAZQPHXLWMOJ-UHFFFAOYSA-N 0.000 description 2
- 230000000202 analgesic effect Effects 0.000 description 2
- 230000000844 anti-bacterial effect Effects 0.000 description 2
- 230000001580 bacterial effect Effects 0.000 description 2
- 239000002775 capsule Substances 0.000 description 2
- 230000008859 change Effects 0.000 description 2
- 230000006378 damage Effects 0.000 description 2
- 229940079593 drug Drugs 0.000 description 2
- 239000005556 hormone Substances 0.000 description 2
- 229940088597 hormone Drugs 0.000 description 2
- 230000005764 inhibitory process Effects 0.000 description 2
- 230000003020 moisturizing effect Effects 0.000 description 2
- 210000001732 sebaceous gland Anatomy 0.000 description 2
- 230000035945 sensitivity Effects 0.000 description 2
- 238000002560 therapeutic procedure Methods 0.000 description 2
- UIAGMCDKSXEBJQ-IBGZPJMESA-N 3-o-(2-methoxyethyl) 5-o-propan-2-yl (4s)-2,6-dimethyl-4-(3-nitrophenyl)-1,4-dihydropyridine-3,5-dicarboxylate Chemical compound COCCOC(=O)C1=C(C)NC(C)=C(C(=O)OC(C)C)[C@H]1C1=CC=CC([N+]([O-])=O)=C1 UIAGMCDKSXEBJQ-IBGZPJMESA-N 0.000 description 1
- 206010000501 Acne conglobata Diseases 0.000 description 1
- 208000020154 Acnes Diseases 0.000 description 1
- 206010011732 Cyst Diseases 0.000 description 1
- 201000004624 Dermatitis Diseases 0.000 description 1
- 241000508725 Elymus repens Species 0.000 description 1
- 206010020751 Hypersensitivity Diseases 0.000 description 1
- 229930183118 Tanshinone Natural products 0.000 description 1
- FEWJPZIEWOKRBE-UHFFFAOYSA-N Tartaric acid Natural products [H+].[H+].[O-]C(=O)C(O)C(O)C([O-])=O FEWJPZIEWOKRBE-UHFFFAOYSA-N 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- -1 acupuncture Substances 0.000 description 1
- 208000026935 allergic disease Diseases 0.000 description 1
- 230000007815 allergy Effects 0.000 description 1
- 239000003098 androgen Substances 0.000 description 1
- 239000002260 anti-inflammatory agent Substances 0.000 description 1
- 230000000845 anti-microbial effect Effects 0.000 description 1
- 230000001741 anti-phlogistic effect Effects 0.000 description 1
- 229940088710 antibiotic agent Drugs 0.000 description 1
- 239000007864 aqueous solution Substances 0.000 description 1
- 230000033228 biological regulation Effects 0.000 description 1
- 239000008280 blood Substances 0.000 description 1
- 210000004369 blood Anatomy 0.000 description 1
- 210000004204 blood vessel Anatomy 0.000 description 1
- 238000009395 breeding Methods 0.000 description 1
- 230000001488 breeding effect Effects 0.000 description 1
- 239000002729 catgut Substances 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 208000037976 chronic inflammation Diseases 0.000 description 1
- 230000006020 chronic inflammation Effects 0.000 description 1
- 238000004140 cleaning Methods 0.000 description 1
- 239000011248 coating agent Substances 0.000 description 1
- 238000000576 coating method Methods 0.000 description 1
- 238000004891 communication Methods 0.000 description 1
- 230000003750 conditioning effect Effects 0.000 description 1
- 208000031513 cyst Diseases 0.000 description 1
- 230000006196 deacetylation Effects 0.000 description 1
- 238000003381 deacetylation reaction Methods 0.000 description 1
- 238000001514 detection method Methods 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 210000002919 epithelial cell Anatomy 0.000 description 1
- 230000005713 exacerbation Effects 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 210000003780 hair follicle Anatomy 0.000 description 1
- 241000411851 herbal medicine Species 0.000 description 1
- 230000003054 hormonal effect Effects 0.000 description 1
- 230000036039 immunity Effects 0.000 description 1
- 238000002513 implantation Methods 0.000 description 1
- 238000001727 in vivo Methods 0.000 description 1
- 208000015181 infectious disease Diseases 0.000 description 1
- 230000002757 inflammatory effect Effects 0.000 description 1
- 239000012528 membrane Substances 0.000 description 1
- 244000005700 microbiome Species 0.000 description 1
- 229960000715 nimodipine Drugs 0.000 description 1
- 239000003960 organic solvent Substances 0.000 description 1
- 230000002688 persistence Effects 0.000 description 1
- 239000000049 pigment Substances 0.000 description 1
- 239000000843 powder Substances 0.000 description 1
- 239000002994 raw material Substances 0.000 description 1
- 208000017520 skin disease Diseases 0.000 description 1
- 235000002906 tartaric acid Nutrition 0.000 description 1
- 239000011975 tartaric acid Substances 0.000 description 1
- 235000019640 taste Nutrition 0.000 description 1
- 230000000699 topical effect Effects 0.000 description 1
- 238000009941 weaving Methods 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
- A61K8/97—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/23—Apiaceae or Umbelliferae (Carrot family), e.g. dill, chervil, coriander or cumin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/25—Araliaceae (Ginseng family), e.g. ivy, aralia, schefflera or tetrapanax
- A61K36/258—Panax (ginseng)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
- A61K36/287—Chrysanthemum, e.g. daisy
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/42—Cucurbitaceae (Cucumber family)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
- A61K36/484—Glycyrrhiza (licorice)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/53—Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
- A61K36/533—Leonurus (motherwort)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/53—Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
- A61K36/537—Salvia (sage)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/73—Rosaceae (Rose family), e.g. strawberry, chokeberry, blackberry, pear or firethorn
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/73—Rosaceae (Rose family), e.g. strawberry, chokeberry, blackberry, pear or firethorn
- A61K36/734—Crataegus (hawthorn)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/75—Rutaceae (Rue family)
- A61K36/752—Citrus, e.g. lime, orange or lemon
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
- A61K8/34—Alcohols
- A61K8/345—Alcohols containing more than one hydroxy group
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
- A61K8/36—Carboxylic acids; Salts or anhydrides thereof
- A61K8/365—Hydroxycarboxylic acids; Ketocarboxylic acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
- A61K8/73—Polysaccharides
- A61K8/736—Chitin; Chitosan; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q17/00—Barrier preparations; Preparations brought into direct contact with the skin for affording protection against external influences, e.g. sunlight, X-rays or other harmful rays, corrosive materials, bacteria or insect stings
- A61Q17/005—Antimicrobial preparations
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/30—Extraction of the material
- A61K2236/33—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones
- A61K2236/331—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones using water, e.g. cold water, infusion, tea, steam distillation or decoction
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/30—Extraction of the material
- A61K2236/33—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones
- A61K2236/333—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones using mixed solvents, e.g. 70% EtOH
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/30—Extraction of the material
- A61K2236/39—Complex extraction schemes, e.g. fractionation or repeated extraction steps
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/50—Methods involving additional extraction steps
- A61K2236/51—Concentration or drying of the extract, e.g. Lyophilisation, freeze-drying or spray-drying
Landscapes
- Health & Medical Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Microbiology (AREA)
- Botany (AREA)
- Engineering & Computer Science (AREA)
- Mycology (AREA)
- Biotechnology (AREA)
- Alternative & Traditional Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Medical Informatics (AREA)
- Chemical & Material Sciences (AREA)
- Birds (AREA)
- Dermatology (AREA)
- Emergency Medicine (AREA)
- Cosmetics (AREA)
Abstract
sa本发明涉及一种用于防治痤疮的护肤面膜液、制备方法及护肤面膜,该护肤面膜液包含以下重量份数的组分:水溶性壳聚糖1‑2份、菊花水煎液5‑10份、中药提取物5‑8份、丝瓜水1.0‑2.0份、乳酸0.5‑1.0份、甘油5‑10份、表面活性剂0.1‑0.2份、去离子水70‑80份;所述中药提取物是以下中药原料的乙醇水提取物:丹参、陈皮、益母草、枇杷叶、田七、山楂、甘草根。该护肤面膜液温和不刺激,副作用小;对痤疮丙酸杆菌、金黄色葡萄球菌和白色葡萄球菌具有良好的抑菌性,且能均衡皮肤油脂分泌、去除皮肤多余油脂、除菌抗炎、改善毛囊皮脂腺导管异常角化并促进痤疮皮损修复,因而对痤疮具有良好的防治作用。
Description
技术领域
本发明属于护肤品技术领域,具体涉及一种用于防治痤疮的护肤面膜液,同时还涉及一种用于防治痤疮的护肤面膜液的制备方法及采用该面膜液的护肤面膜。
背景技术
痤疮俗称“青春痘”、“粉刺”,是一种常见的累及毛囊、皮脂腺的损容性慢性炎症性皮肤病,主要发生在面部、胸背部,形成粉刺、丘疹、脓包、结节、囊肿、瘢痕等损害;一般多发于15-30岁青年男女,由于其具有多行性、反复性、易变性及持久性等特点,常对患者的形象、工作及生活、人际交往等产生负面影响。
现代医学认为痤疮的发生是体内激素水平的改变、毛囊皮脂腺导管异常角化、皮脂膜的破坏(皮脂分泌增多)和微生物过度繁殖等多因素共同作用的结果。故目前临床上对痤疮的治疗是以药物口服以改善体内的雄激素水平、消除炎症,以及药物外用以减少皮肤炎症的发生及色素的沉着和瘢痕的遗留。但是,由于西药多采用激素成分,治疗过程中存在副作用,患者在治疗过程中依从性差、容易复发或者容易并发其他的面部皮损,如激素依赖皮炎等,其效果具有局限性。由于痤疮多发于面部,人们对于治疗的效果以及副作用或是不良反应都有着较高的要求,故越来越多的患者选择中医的方法治疗痤疮。
中医上用于治疗痤疮的方法较为广泛,如口服中药、针刺、穴位埋线、耳针、拔罐、推拿等,其治疗多侧重于体质方面的调理,一般周期较长,效果不确切;且诸如针刺、埋线等也伴随着身体上的痛苦,患者心理上较为抗拒,依从性差,很难长期坚持治疗。随着社会的发展和人们对于自身形象的追求,面膜已经成为人们日常的护肤消费品之一,采用面膜护肤已经是很多人日常生活的一部分。在中药外治的方法中,中药面膜是将具有消炎镇痛、活血化瘀作用的中药制成粉剂,用水混合成膏状,涂覆于面部,可在一定程度上消除炎症,加速有效成分的吸收。但是该中药面膜粉剂需要先加水混合,浓稠度不好掌握,涂覆及移除都比较费时费力,不利于日常使用;同时中药粉剂外用于皮肤表面,中药材的有效成分没有得到充分释放,与皮肤的接触量小,吸收效果差,作用不理想。因此,如何开发一种方便使用且效果显著的防治痤疮的护肤面膜,是需要解决的问题。
发明内容
本发明的目的是提供一种用于防治痤疮的护肤面膜液,使用方便且效果显著。
本发明的第二个目的是提供一种用于防治痤疮的护肤面膜液的制备方法。
本发明的第三个目的是提供一种采用上述用于防治痤疮的护肤面膜液的护肤面膜。
为了实现上述目的,本发明所采用的技术方案为:
一种用于防治痤疮的护肤面膜液,包含以下重量份数的组分:水溶性壳聚糖1-2份、菊花水煎液5-10份、中药提取物5-8份、丝瓜水0.5-1.0份、乳酸0.5-1.0份、甘油5-10份、表面活性剂0.1-0.2份、去离子水70-80份;
其中,所述菊花水煎液是采用甜叶菊、绣线菊与洋甘菊按照质量比为1:(0.8-1):(0.8-1)的比例混合后加水煎煮后,经过滤所得的滤液;
所述中药提取物是以下重量份数的中药原料的乙醇水提取物:丹参8-10份、陈皮8-10份、益母草4-5份、枇杷叶4-5份、田七2-3份、山楂2-3份、甘草根1-2份。
所述表面活性剂为吐温-80。
一种上述的用于防治痤疮的护肤面膜液的制备方法,包括以下步骤:
1)按照甜叶菊、绣线菊与洋甘菊的质量比为1:(0.8-1):(0.8-1)的比例,将三者混合,加水浸泡后煎煮30-40min,固液分离后在药渣中加水二次煎煮,合并两次煎煮液,过滤除去杂质后浓缩得菊花水煎液;
2)将各中药原料粉碎后,按重量份数取丹参8-10份、陈皮8-10份、益母草4-5份、枇杷叶4-5份、田七2-3份、山楂2-3份、甘草根1-2份混合,用乙醇体积含量为70%-75%的乙醇水溶液进行回流提取,提取液经过滤除去杂质后,减压浓缩除去乙醇,得中药提取物;
3)取配方量的乳酸加入水中溶解后,加入水溶性壳聚糖搅拌溶解,后加入丝瓜水和步骤1)所得菊花水煎液,得混合液A;
将配方量的步骤2)所得中药提取物和表面活性剂加入甘油中混合均匀后得混合物B;再将混合物A与混合物B混合,进行均质乳化,即得。
步骤1)中,菊花煎煮液浓缩至比重为1.15-1.20。
步骤2)中,所述回流提取是采用6-10倍量的乙醇水溶液进行回流提取2次,每次1-2h。
步骤2)中,所得中药提取物的比重为1.25-1.35。
步骤3)中,所述均质乳化的转速为8000-10000rpm,时间为20-30min。
一种采用上述的用于防治痤疮的护肤面膜液的护肤面膜。该护肤面膜是将水刺非织造面膜基布浸入所述护肤面膜液中使其持液;持液量与面膜基布的质量比为10-12:1。
本发明的用于防治痤疮的护肤面膜液,采用菊花水煎液和中药提取物作为主要功效成分,菊花水煎液采用甜叶菊、绣线菊与洋甘菊为原料,水煎液具有皮脂分泌调节的作用,可以均衡油脂分泌,恢复皮肤油水平衡;中药提取物为丹参、陈皮、益母草、枇杷叶、田七、山楂、甘草根这七味中药材的乙醇水提取物,其中丹参具有抑菌除菌、抗炎免疫的功效,陈皮具有皮脂分泌调节的功效,枇杷叶具有抗菌抗炎、减少皮脂分泌的功效,田七具有抗毛囊皮脂腺导管角化的功效,山楂具有软化血管、溶解毛细角栓的功效,茅草根具有皮肤舒缓作用,诸药合用,多种功效相互配合,从根本上抑制痤疮的产生。同时,辅以水溶性壳聚糖菊、丝瓜水、乳酸、甘油、表面活性剂,其中水溶性壳聚糖本身具有良好的抗菌、消炎、止痛的作用,可以防止过敏、感染等反应,并能促进面部微小创伤愈合,促进痤疮快速收口,同时壳聚糖具有良好的成膜性,能使得面膜液更好的在面膜基布上挂液,提高持液性。丝瓜水具有舒缓皮肤和保湿的作用,能修复痤疮皮损、防止瘢痕产生;乳酸作为较为温和的果酸,使得面膜液维持在弱酸性,能增加上皮细胞的流通和脱落,有助于剥离粉刺痤疮;甘油作为保湿剂和有机溶剂使用。
本发明的用于防治痤疮的护肤面膜液,采用菊花水煎液和中药提取物作为主要功效成分,辅以水溶性壳聚糖菊、丝瓜水、乳酸、甘油、表面活性剂,与去离子水复配成面膜精华液;主要成分均为中草药提取物,温和不刺激,副作用小;对痤疮丙酸杆菌、金黄色葡萄球菌和白色葡萄球菌具有良好的抑菌性,且能均衡皮肤油脂分泌、去除皮肤多余油脂、除菌抗炎、改善毛囊皮脂腺导管异常角化并促进痤疮皮损修复,因而对痤疮具有良好的防治作用。
采用本发明的用于防治痤疮的护肤面膜液制成的护肤面膜,使用时贴于面部,保持20-30min后,用手揭下,清水洗去面部残留面膜液即可;作为日常护肤面膜使用,方便快捷,一周使用2-3次,可达到良好的防治痤疮的效果。
具体实施方式
下面结合具体实施方式对本发明做进一步的说明。
具体实施方式中,所用表面活性剂为吐温-80;所用的水均为去离子水;所用水溶性壳聚糖的脱乙酰度为50%左右,分子量为(0.8-1.2)×104。所用丝瓜水为市售丝瓜原液。
实施例1
本实施例的用于防治痤疮的护肤面膜液,包含以下重量份数的组分:水溶性壳聚糖1.0份、菊花水煎液7份、中药提取物8份、丝瓜水0.5份、乳酸0.5份、甘油10份、表面活性剂0.2份、去离子水72.5份;
其中,所述菊花水煎液是采用甜叶菊、绣线菊与洋甘菊按照质量比为1:1:1的比例混合后加水煎煮后,经过滤所得的滤液;
所述中药提取物是以下重量份数的中药原料的乙醇水提取物:丹参8份、陈皮10份、益母草4份、枇杷叶5份、田七2份、山楂3份、甘草根2份。
本实施例的用于防治痤疮的护肤面膜液的制备方法,包括以下步骤:
1)按照甜叶菊、绣线菊与洋甘菊的质量比为1:1:1的比例,将三者混合,加6倍量的水浸泡30min后煎煮30min,固液分离后在药渣中加6倍量的水二次煎煮30min,合并两次煎煮液,过滤除去杂质后浓缩得比重为1.20的菊花水煎液;
2)将各中药原料粉碎后,按重量份数取丹参、陈皮、益母草、枇杷叶、田七、山楂、甘草根混合,用8倍量的乙醇体积含量为70%的乙醇水溶液进行2次回流提取,每次1.5h,合并提取液,经过滤除去杂质后,减压浓缩除去乙醇,得比重为1.30的中药提取物;
3)取配方量的乳酸加入去离子水中溶解后,加入水溶性壳聚糖搅拌溶解,后加入丝瓜水和步骤1)所得菊花水煎液,得混合液A;
将配方量的步骤2)所得中药提取物和表面活性剂加入甘油中混合均匀后得混合物B;再将混合物A与混合物B混合,在8000rpm条件下进行均质乳化30min,即得所述护肤面膜液。
本实施例的采用上述用于防治痤疮的护肤面膜液的护肤面膜,是将水刺非织造面膜基布浸入所述护肤面膜液中使其持液,持液量与面膜基布的质量比为10:1。
实施例2
本实施例的用于防治痤疮的护肤面膜液,包含以下重量份数的组分:水溶性壳聚糖1.5份、菊花水煎液10份、中药提取物5份、丝瓜水0.8份、乳酸0.7份、甘油6份、表面活性剂0.2份、去离子水75.6份;
其中,所述菊花水煎液是采用甜叶菊、绣线菊与洋甘菊按照质量比为1:.0.8:1的比例混合后加水煎煮后,经过滤所得的滤液;
所述中药提取物是以下重量份数的中药原料的乙醇水提取物:丹参9份、陈皮9份、益母草5份、枇杷叶4份、田七3份、山楂2份、甘草根1份。
本实施例的用于防治痤疮的护肤面膜液的制备方法,包括以下步骤:
1)按照甜叶菊、绣线菊与洋甘菊的质量比为1:0.8:1的比例,将三者混合,加8倍量的水浸泡30min后煎煮40min,固液分离后在药渣中加8倍量的水二次煎煮40min,合并两次煎煮液,过滤除去杂质后浓缩得比重为1.15的菊花水煎液;
2)将各中药原料粉碎后,按重量份数取丹参、陈皮、益母草、枇杷叶、田七、山楂、甘草根混合,用6倍量的乙醇体积含量为75%的乙醇水溶液进行2次回流提取,每次2.0h,合并提取液,经过滤除去杂质后,减压浓缩除去乙醇,得比重为1.35的中药提取物;
3)取配方量的乳酸加入去离子水中溶解后,加入水溶性壳聚糖搅拌溶解,后加入丝瓜水和步骤1)所得菊花水煎液,得混合液A;
将配方量的步骤2)所得中药提取物和表面活性剂加入甘油中混合均匀后得混合物B;再将混合物A与混合物B混合,在10000rpm条件下进行均质乳化20min,即得所述护肤面膜液。
本实施例的采用上述用于防治痤疮的护肤面膜液的护肤面膜,是将水刺非织造面膜基布浸入所述护肤面膜液中使其持液,持液量与面膜基布的质量比为11:1。
实施例3
本实施例的用于防治痤疮的护肤面膜液,包含以下重量份数的组分:水溶性壳聚糖2.0份、菊花水煎液5份、中药提取物6份、丝瓜水1.0份、乳酸1.0份、甘油8份、表面活性剂0.2份、去离子水76.4份;
其中,所述菊花水煎液是采用甜叶菊、绣线菊与洋甘菊按照质量比为1:0.8:0.8的比例混合后加水煎煮后,经过滤所得的滤液;
所述中药提取物是以下重量份数的中药原料的乙醇水提取物:丹参10份、陈皮8份、益母草4份、枇杷叶5份、田七3份、山楂2份、甘草根2份。
本实施例的用于防治痤疮的护肤面膜液的制备方法,包括以下步骤:
1)按照甜叶菊、绣线菊与洋甘菊的质量比为1:0.8:0.8的比例,将三者混合,加7倍量的水浸泡30min后煎煮40min,固液分离后在药渣中加6倍量的水二次煎煮30min,合并两次煎煮液,过滤除去杂质后浓缩得比重为1.17的菊花水煎液;
2)将各中药原料粉碎后,按重量份数取丹参、陈皮、益母草、枇杷叶、田七、山楂、甘草根混合,用10倍量的乙醇体积含量为70%的乙醇水溶液进行2次回流提取,每次1.0h,合并提取液,经过滤除去杂质后,减压浓缩除去乙醇,得比重为1.25的中药提取物;
3)取配方量的乳酸加入去离子水中溶解后,加入水溶性壳聚糖搅拌溶解,后加入丝瓜水和步骤1)所得菊花水煎液,得混合液A;
将配方量的步骤2)所得中药提取物和表面活性剂加入甘油中混合均匀后得混合物B;再将混合物A与混合物B混合,在8000rpm条件下进行均质乳化30min,即得所述护肤面膜液。
本实施例的采用上述用于防治痤疮的护肤面膜液的护肤面膜,是将水刺非织造面膜基布浸入所述护肤面膜液中使其持液,持液量与面膜基布的质量比为12:1。
实验例1
本实验例对实施例1-3所得护肤面膜液的抑菌性进行检测,检测方法为通过纸片法进行抑菌圈测定;实验所用菌株均为市售标准菌株。结果如表1所示。
表1实施例1-3所得护肤面膜液的抑菌性检测结果
参照抗菌药物的敏感性评定标准(抑菌圈大于20mm为高敏,10-20mm为敏感,小于10mm为耐药),从表1可以看出,痤疮丙酸杆菌和金黄色葡萄球菌对实施例1-3的护肤面膜液均为高敏,白色葡萄球菌为敏感。上述三种菌的滋生和繁殖是导致痤疮发生的原因之一,实验结果表明,本发明的护肤面膜液对上述三种菌具有良好的抑菌性,可以通过抑制细菌滋生和增殖达到防治痤疮的作用。
实验例2
本实验例对实施例1所得护肤面膜的效果进行试验。观察对象为近一年内的痤疮患者,年龄为18-30岁,病程为4个月到10年,将40名患者随机分成两组(治疗组和对照组),每组20例。
诊断标准:按Pillsbury分类法属于III-VI级痤疮,表现为大量丘疹和脓疱,偶见大的炎性皮损,分布广泛,或结节性、囊肿型或聚合性痤疮,伴疼痛并形成囊肿。
实验方法:治疗组在清洁面部后,采用实施例1所得护肤面膜进行贴面,保持20-30min后,用手揭下,清水洗去面部残留面膜液;每周2次,连续6周。对照组口服丹参酮胶囊,每次4粒,每天三次;同时外用维A酸乳膏,每天两次;连续6周。
疗效评价标准:按四级疗效标准评定,计算公式(尼莫地平法):
疗效指数=(治疗前皮损总数-治疗后皮损总数)/治疗前皮损总数×100%。
参照《寻常痤疮严重程度分级和疗效判定标准》进行疗效评价:
痊愈:皮损基本消退,疼痛感消失,疗效指数>90%;
显效:皮损明显消退,疼痛感明显减轻,疗效指数61%-90%;
有效:皮损有所消退,疼痛感减轻,疗效指数20%-60%;
无效:皮损消退很少或无明显改变或加重,疼痛感未减轻或加剧,疗效指数<20%。
总有效率为痊愈、显效、有效例数之和与总病例数的比值。结果如表2所示。
表2实施例1所得护肤面膜的试验结果
组别 | 例数 | 痊愈 | 显效 | 有效 | 无效 | 总有效率(%) |
治疗组 | 20 | 8 | 7 | 4 | 1 | 95 |
对照组 | 20 | 4 | 5 | 4 | 7 | 65 |
从表2可以看出,两组疗效比较有显著性差异(P<0.05),且两组均未出现严重不良反应现象。治疗组的痊愈者半年后随访无复发。试验结果表明,采用本发明的护肤面膜液的护肤面膜,面膜中的有效成分能直接作用于面部病变部位,与肌肤的接触面积大,肌肤对有效成分的吸收率高,各组分相互配合、协调作用,对痤疮的治疗效果显著,适合推广使用。
Claims (8)
1.一种用于防治痤疮的护肤面膜液,其特征在于:包含以下重量份数的组分:水溶性壳聚糖1-2份、菊花水煎液5-10份、中药提取物5-8份、丝瓜水1.0-2.0份、乳酸0.5-1.0份、甘油5-10份、表面活性剂0.1-0.2份、去离子水70-80份;
其中,所述菊花水煎液是采用甜叶菊、绣线菊与洋甘菊按照质量比为1:(0.8-1):(0.8-1)的比例混合后加水煎煮后,经过滤所得的滤液;
所述中药提取物是以下重量份数的中药原料的乙醇水提取物:丹参8-10份、陈皮8-10份、益母草4-5份、枇杷叶4-5份、田七2-3份、山楂2-3份、甘草根1-2份。
2.根据权利要求1所述的用于防治痤疮的护肤面膜液,其特征在于:所述表面活性剂为吐温-80。
3.一种如权利要求1所述的用于防治痤疮的护肤面膜液的制备方法,其特征在于:包括以下步骤:
1)按照甜叶菊、绣线菊与洋甘菊的质量比为1:(0.8-1):(0.8-1)的比例,将三者混合,加水浸泡后煎煮30-40min,固液分离后在药渣中加水二次煎煮,合并两次煎煮液,过滤除去杂质后浓缩得菊花水煎液;
2)将各中药原料粉碎后,按重量份数取丹参8-10份、陈皮8-10份、益母草4-5份、枇杷叶4-5份、田七2-3份、山楂2-3份、甘草根1-2份混合,用乙醇体积含量为70%-75%的乙醇水溶液进行回流提取,提取液经过滤除去杂质后,减压浓缩除去乙醇,得中药提取物;
3)取配方量的乳酸加入水中溶解后,加入水溶性壳聚糖搅拌溶解,后加入丝瓜水和步骤1)所得菊花水煎液,得混合液A;
将配方量的步骤2)所得中药提取物和表面活性剂加入甘油中混合均匀后得混合物B;再将混合物A与混合物B混合,进行均质乳化,即得。
4.根据权利要求3所述的用于防治痤疮的护肤面膜液的制备方法,其特征在于:步骤1)中,菊花煎煮液浓缩至比重为1.15-1.20。
5.根据权利要求3所述的用于防治痤疮的护肤面膜液的制备方法,其特征在于:步骤2)中,所述回流提取是采用6-10倍量的乙醇水溶液进行回流提取2次,每次1-2h。
6.根据权利要求3或5所述的用于防治痤疮的护肤面膜液的制备方法,其特征在于:所得中药提取物的比重为1.25-1.35。
7.根据权利要求3所述的用于防治痤疮的护肤面膜液的制备方法,其特征在于:步骤3)中,所述均质乳化的转速为8000-10000rpm,时间为20-30min。
8.一种采用如权利要求1所述的用于防治痤疮的护肤面膜液的护肤面膜。
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201710638134.XA CN107375075A (zh) | 2017-07-31 | 2017-07-31 | 一种用于防治痤疮的护肤面膜液、制备方法及护肤面膜 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201710638134.XA CN107375075A (zh) | 2017-07-31 | 2017-07-31 | 一种用于防治痤疮的护肤面膜液、制备方法及护肤面膜 |
Publications (1)
Publication Number | Publication Date |
---|---|
CN107375075A true CN107375075A (zh) | 2017-11-24 |
Family
ID=60341390
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201710638134.XA Pending CN107375075A (zh) | 2017-07-31 | 2017-07-31 | 一种用于防治痤疮的护肤面膜液、制备方法及护肤面膜 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN107375075A (zh) |
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN108078879A (zh) * | 2017-12-11 | 2018-05-29 | 华南农业大学 | 用于防治痤疮丙酸杆菌的黄香楝-百合提取物及其应用 |
CN110251429A (zh) * | 2019-06-10 | 2019-09-20 | 江门职业技术学院 | 陈皮提取物在控油化妆品中的应用 |
CN110638692A (zh) * | 2019-10-30 | 2020-01-03 | 华南理工大学 | 一种具有抑制青春痘作用的面膜液及其制备方法 |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1621082A (zh) * | 2003-11-26 | 2005-06-01 | 岐黄药业科技投资有限责任公司 | 治疗痤疮的中药组合物 |
CN103169641A (zh) * | 2013-03-14 | 2013-06-26 | 金红叶纸业集团有限公司 | 祛痘淡印组合物及应用其的纸巾 |
CN106511473A (zh) * | 2016-10-25 | 2017-03-22 | 西南大学 | 一种抗菌祛痘、治疗疱疹的中药提取液及其应用与其制备的护肤乳 |
-
2017
- 2017-07-31 CN CN201710638134.XA patent/CN107375075A/zh active Pending
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1621082A (zh) * | 2003-11-26 | 2005-06-01 | 岐黄药业科技投资有限责任公司 | 治疗痤疮的中药组合物 |
CN103169641A (zh) * | 2013-03-14 | 2013-06-26 | 金红叶纸业集团有限公司 | 祛痘淡印组合物及应用其的纸巾 |
CN106511473A (zh) * | 2016-10-25 | 2017-03-22 | 西南大学 | 一种抗菌祛痘、治疗疱疹的中药提取液及其应用与其制备的护肤乳 |
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN108078879A (zh) * | 2017-12-11 | 2018-05-29 | 华南农业大学 | 用于防治痤疮丙酸杆菌的黄香楝-百合提取物及其应用 |
CN110251429A (zh) * | 2019-06-10 | 2019-09-20 | 江门职业技术学院 | 陈皮提取物在控油化妆品中的应用 |
CN110638692A (zh) * | 2019-10-30 | 2020-01-03 | 华南理工大学 | 一种具有抑制青春痘作用的面膜液及其制备方法 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN100391517C (zh) | 一种治疗烧烫冻伤的药物及其制备方法 | |
CN101019948A (zh) | 治疗痤疮的中药复方制剂 | |
CN104208153B (zh) | 一种治疗皮肤病的中药组合物及其制剂 | |
CN107375075A (zh) | 一种用于防治痤疮的护肤面膜液、制备方法及护肤面膜 | |
CN102872241A (zh) | 一种用于治疗炎症性皮肤病的中药组合物及其制剂 | |
CN102335342B (zh) | 一种用于治疗黄褐斑的中药组合物及其制备方法和应用 | |
CN101837082B (zh) | 治疗烧伤的中药制剂 | |
CN101897868B (zh) | 一种治疗银屑病的中药组合物及其制备方法 | |
CN101439114B (zh) | 一种治疗烧烫伤的中药及其制备方法 | |
CN102335231B (zh) | 一种用于治疗黄褐斑的中药润肤霜及其制备方法和应用 | |
CN107913301A (zh) | 一种用于女性私处养护的中药组合物及其含该组合物提取物的精华液 | |
CN103721138B (zh) | 一种治疗酒糟鼻的中药外用制剂及其制备方法 | |
CN106236650B (zh) | 一种祛痘控油乳膏剂及其制备方法 | |
CN105497537A (zh) | 一种具有美白嫩肤作用的药物组合物及其制备方法 | |
CN104983817A (zh) | 一种治疗脂溢性脱发的酊剂及其制备方法 | |
JP5561365B2 (ja) | 持続性鎮痒外皮用剤 | |
CN104147198A (zh) | 一种治疗丘疹性痤疮中药复方及其制剂 | |
CN105148150A (zh) | 一种保健茶及其制备方法 | |
CN110393772A (zh) | 一种促进放疗患者皮肤伤口愈合的药物组合物及制备方法 | |
CN108785467A (zh) | 一种紫花地丁软膏及其制备方法 | |
KR20200008289A (ko) | 인설 예방 및 완화용 한약재 조성물 | |
CN109925468A (zh) | 一种预防乳腺炎的中药护乳垫 | |
CN108283670A (zh) | 一种治疗烧烫伤的药物组合物及其制备方法 | |
CN102716217B (zh) | 一种治疗痤疮的药物组合物 | |
CN107929346A (zh) | 治疗湿疹的中药组合物及其制备方法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
RJ01 | Rejection of invention patent application after publication | ||
RJ01 | Rejection of invention patent application after publication |
Application publication date: 20171124 |